Literature DB >> 8950072

Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.

S Lepage1, D Bonnefont-Rousselot, E Bruckert, B Bourely, M C Jaudon, J Delattre, U Assogba.   

Abstract

Oxidation of low density lipoprotein is involved in the pathogenesis of atherosclerosis. Epidemiological studies suggest a negative correlation between the occurrence of cardiovascular diseases and blood concentrations of lipophilic antioxidants such as vitamins A and E and beta-carotene. Trace elements, such as selenium, zinc, and copper, are involved in the activity of the antioxidant enzymes glutathione peroxidase and superoxide dismutase. The aim of this study was to determine the antioxidant and trace element status of patients with severe hypercholesterolemia who had been treated with dextran-sulphate low-density lipoprotein apheresis in comparison with two control populations, normocholesterolemic subjects and untreated hypercholesterolemic patients. Our results showed that, patients treated with LDL apheresis, compared with normocholesteromic subjects, were not deficient in vitamin E, beta-carotene, and copper, but had lower plasma levels of selenium, zinc, and vitamin A. The low selenium and vitamin A levels were due to the LDL-apheresis treatment, and the hypercholesterolemia might have provoked the low plasma levels of zinc. The study pointed out the potential benefits of supplemental selenium, zinc, and vitamin A in patients being treated with LDL apheresis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950072     DOI: 10.1007/bf00050998

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  33 in total

1.  Treatment of homozygous familial hypercholesterolemia by plasma exchange and LDL-apheresis.

Authors:  J B Palcoux; M Meyer; P Jouanel; A Tridon; P Vanlieferinghen; H Carla; G Malpuech
Journal:  Transfus Sci       Date:  1993-10

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 3.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

4.  Chromatography of selenoproteins in human serum using matrix-bound heparin.

Authors:  B Akesson; B Mårtensson
Journal:  Int J Vitam Nutr Res       Date:  1991       Impact factor: 1.784

Review 5.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

Review 6.  The interaction of vitamin A and zinc: implications for human nutrition.

Authors:  N W Solomons; R M Russell
Journal:  Am J Clin Nutr       Date:  1980-09       Impact factor: 7.045

7.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene.

Authors:  R A Riemersma; D A Wood; C C Macintyre; R A Elton; K F Gey; M F Oliver
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

8.  Oxidation of low-density lipoproteins by OH. and OH./O2-. free radicals produced by gamma radiolysis.

Authors:  D Bonnefont-Rousselot; M Gardès-Albert; J Delattre; C Ferradini
Journal:  Radiat Res       Date:  1993-06       Impact factor: 2.841

9.  Vitamin E consumption and the risk of coronary disease in women.

Authors:  M J Stampfer; C H Hennekens; J E Manson; G A Colditz; B Rosner; W C Willett
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

10.  Structure and mechanism of copper, zinc superoxide dismutase.

Authors:  J A Tainer; E D Getzoff; J S Richardson; D C Richardson
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

View more
  1 in total

Review 1.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.